Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP415361.RA5dKd3UKSRLUGW8MGTfexDYS5K6GJWjMfGqRd8C9LcZ0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP415361.RA5dKd3UKSRLUGW8MGTfexDYS5K6GJWjMfGqRd8C9LcZ0130_assertion type Assertion NP415361.RA5dKd3UKSRLUGW8MGTfexDYS5K6GJWjMfGqRd8C9LcZ0130_head.
- NP415361.RA5dKd3UKSRLUGW8MGTfexDYS5K6GJWjMfGqRd8C9LcZ0130_assertion description "[We examine the long-term effects of a thyrotropin-releasing hormone (TRH) analogue, CNK-602A, acute administration of which was effective inhibiting both types of seizures in SER, to determine if this agent could be used to treat epilepsy for long periods.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP415361.RA5dKd3UKSRLUGW8MGTfexDYS5K6GJWjMfGqRd8C9LcZ0130_provenance.
- NP415361.RA5dKd3UKSRLUGW8MGTfexDYS5K6GJWjMfGqRd8C9LcZ0130_assertion evidence source_evidence_literature NP415361.RA5dKd3UKSRLUGW8MGTfexDYS5K6GJWjMfGqRd8C9LcZ0130_provenance.
- NP415361.RA5dKd3UKSRLUGW8MGTfexDYS5K6GJWjMfGqRd8C9LcZ0130_assertion SIO_000772 8603636 NP415361.RA5dKd3UKSRLUGW8MGTfexDYS5K6GJWjMfGqRd8C9LcZ0130_provenance.
- NP415361.RA5dKd3UKSRLUGW8MGTfexDYS5K6GJWjMfGqRd8C9LcZ0130_assertion wasDerivedFrom befree-20140225 NP415361.RA5dKd3UKSRLUGW8MGTfexDYS5K6GJWjMfGqRd8C9LcZ0130_provenance.
- NP415361.RA5dKd3UKSRLUGW8MGTfexDYS5K6GJWjMfGqRd8C9LcZ0130_assertion wasGeneratedBy ECO_0000203 NP415361.RA5dKd3UKSRLUGW8MGTfexDYS5K6GJWjMfGqRd8C9LcZ0130_provenance.